TBX2 Gene - T-Box Transcription Factor 2: Function, Mutations, and Disease Associations

TBX2 (T-box transcription factor 2) is a member of the T-box family of transcription factors, characterized by a conserved DNA-binding domain (T-box). It plays critical roles in embryonic development, particularly in heart, limb, and neural crest cell patterning. TBX2 acts as a transcriptional repressor by binding to T-box elements in target gene promoters. It is involved in cell cycle regulation, senescence suppression, and apoptosis inhibition. Aberrant expression or mutation of TBX2 is associated with several cancers, including breast, lung, and melanoma, as well as developmental disorders such as ulnar-mammary syndrome and congenital heart defects.

Tissue Expression

Cell Line Expression

Hotspot Mutations

Mutation functional classification

• T-box transcription factor pathway (Reactome: R-HSA-5619507)

• p53-independent G1/S DNA damage checkpoint (KEGG: hsa04110)

• Senescence and autophagy in cancer (WikiPathways: WP615)

TBX2 is a 712-amino acid transcription factor containing a conserved T-box DNA-binding domain. It functions primarily as a transcriptional repressor, binding to T-box elements (TBE) in target gene promoters. Key targets include CDKN1A (p21), CDKN2A (p19ARF), and NPPA. TBX2 represses p21 and p19ARF, thereby inhibiting cell cycle arrest and senescence. The protein localizes to the nucleus and interacts with other transcription factors such as GATA4 and NKX2-5. Post-translational modifications include phosphorylation, which may modulate its activity. TBX2 is essential for heart development, limb patterning, and neural crest cell migration. In cancer, TBX2 overexpression contributes to tumorigenesis by bypassing senescence and promoting proliferation.